Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 01
Prochlorperazine Edisylate Injection
Product Images NDC 23155-294
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Edisylate (NDC 23155-294). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 02
Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 03
Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 04
This is a pharmaceutical product with NDC code 23155-294-31, manufactured by Emcure Pharmaceuticals Ltd. in India. It contains 10 mg/2 mL solution meant for deep IM or IV use only and is not recommended for SC use. The product should be kept away from light and is available in a 2 mL multiple-dose vial with a prescription (Rx) for Avet Pharmaceuticals Inc.*
Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 05
Prochlorperazine is a medication used to treat nausea and vomiting. This text shows information about the injection form of the medication, including the dosage, ingredients, and warnings not to use it in pediatric surgery. The text also includes storage instructions and the temperature range for safe use.*
Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 06
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
